(No ratings)
Dr. Andrew Li Jen Kung, MD PhD is a physician provider in New York, NY specializing in physician, pediatric oncology and transplant surgery. He graduated from Stanford University School of Medicine in 1994 and has 32 years of experience. Dr. Andrew Li Jen Kung, MD PhD is affiliated with Memorial Sloan Kettering Cancer Center.
Dr. Andrew Li Jen Kung, MD PhD graduated from Stanford University School of Medicine in 1994. He completed residency at Children's Hospital Boston. He is certified by the Board Certification: Pediatric Hematology-Oncology and has a state license in Massachusetts.
Medical School: Stanford University School of Medicine (1994)
Residency: Children's Hospital Boston (1996)
Board Certification: Board Certification: Pediatric Hematology-Oncology
Licensed In: Massachusetts
Dr. Andrew Li Jen Kung, MD PhD appears to accept the following insurance providers: Horizon Medicare Advantage, Magnacare, Emblem Medicare Advantage, Fidelis, Oscar, Aetna Medicare Advantage (City of NY retirees only, starting 9/1/23), Healthsmart, United Healthcare, Aetna, Tricare, Oxford, Fidelis Managed Medicaid & HARP, Healthfirst, Cigna, Qualcare, MVP, Connecticare, Healthfirst Medicare Advantage, First Health, Multiplan/Beech Street/PHCS, World Trade Center Health Program (WTC), Blue Cross Blue Shield states outside of NY/NJ, Empire Essential, Non-Participating Plans with Out of Network Benefits, Blue Cross Blue Shield New York, Blue Cross Blue Shield Federal Employee Program, UMR, Medicare Part A&B (traditional Medicare), Carrum Health and Blue Cross Health Plus.
According to our sources, Dr. Andrew Li Jen Kung, MD PhD accepts the following insurance providers:
Dr. Andrew Li Jen Kung, MD PhD does not have any reviews yet, be the first to leave a review of Dr. Andrew Li Jen Kung, MD PhD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Andrew Li Jen Kung, MD PhD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| Karyopharm Therapeutics Inc. |
$16,500
XPOVIO $16,500 |
|---|---|
| Becton, Dickinson and Company |
$205
$205 |
| Eli Lilly and Company |
$190
$190 |
| Genentech, Inc. |
$35
$35 |
| Consulting Fee | $16,705 |
|---|---|
| Food and Beverage | $225 |
Andrew Kung is a physician-scientist and Chair of the Department of Pediatrics at Memorial Sloan Kettering. His clinical expertise is in cancer genomics, precision medicine, and stem cell transplantation.